Our findings expand on this understanding, demonstrating that JAK inhibitors reduce bone resorption and the mRNA expression of inflammatory mediators relevant to periodontitis progression, including Il‐6, Rankl, and Tnf‐α, while also reducing osteoclast numbers. The gene discussed is TNFSF11; the disease is periodontitis.